RankingsPricing
  1. US-listed companies
  2. DEXCOM INC
  3. Financials
  4. Stockholders' equity

DEXCOM INCDXCM

Market cap
$25.8B
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Dec 31, 20242,103+1.64%
Dec 31, 20232,069-2.96%
Dec 31, 20222,132-5.32%
Dec 31, 20212,252+23.27%
Dec 31, 20201,827+106.95%
Dec 31, 2019883+33.06%
Dec 31, 2018663+58.15%
Dec 31, 2017419+47.78%
Dec 31, 2016284+28.30%
Dec 31, 2015221+57.77%
Dec 31, 2014140+66.71%
Dec 31, 201384+9.22%
Dec 31, 201277-26.31%
Dec 31, 2011104

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)